These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26146828)

  • 21. Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.
    Huang TL; Tsai MH; Chuang HC; Chien CY; Lin YT; Tsai WL; Fang FM
    Radiat Oncol; 2020 Apr; 15(1):84. PubMed ID: 32307024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.
    Lee N; Harris J; Garden AS; Straube W; Glisson B; Xia P; Bosch W; Morrison WH; Quivey J; Thorstad W; Jones C; Ang KK
    J Clin Oncol; 2009 Aug; 27(22):3684-90. PubMed ID: 19564532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.
    Wu F; Wang R; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
    Radiother Oncol; 2014 Jul; 112(1):106-11. PubMed ID: 24933452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Wong FC; Ng AW; Lee VH; Lui CM; Yuen KK; Sze WK; Leung TW; Tung SY
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):138-45. PubMed ID: 19646824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma.
    Fangzheng W; Chuner J; Lei W; Weijun C; Min X; Quanquan S; Tongxin L; Aizawa R; Sakamoto M; Zhenfu F
    Oncotarget; 2017 Jun; 8(24):39756-39765. PubMed ID: 28055973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
    Lee N; Xia P; Quivey JM; Sultanem K; Poon I; Akazawa C; Akazawa P; Weinberg V; Fu KK
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):12-22. PubMed ID: 12007936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.
    Tham IW; Lin S; Pan J; Han L; Lu JJ; Wee J
    Am J Clin Oncol; 2010 Jun; 33(3):294-9. PubMed ID: 20395788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: A prospective, real-world study with a large population.
    Wang X; Huang N; Yip PL; Wang J; Huang R; Sun Z; Kang D; He Q; Deng X; Zhao C; Chua MLK; Han F
    Radiother Oncol; 2024 May; 194():110154. PubMed ID: 38367938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events.
    Songthong AP; Kannarunimit D; Chakkabat C; Lertbutsayanukul C
    Radiat Oncol; 2015 Aug; 10():166. PubMed ID: 26253488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.
    Kong FF; Ying H; Du CR; Huang S; Zhou JJ; Hu CS
    PLoS One; 2014; 9(3):e91362. PubMed ID: 24608637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Use of Nimotuzumab in Combination With Intensity-Modulated Radiotherapy and Chemotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: Experience of a Single Institution.
    Fangzheng W; Chuner J; Zhiming Y; Tongxin L; Fengqin Y; Lei W; Bin L; Fujun H; Ming C; Weifeng Q; Zhenfu F
    Oncol Res; 2018 Mar; 26(2):277-287. PubMed ID: 29046165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma.
    Puebla F; Lopez Guerra JL; Garcia Ramirez JM; Matute R; Marrone I; Miguez C; Sevillano D; Sanchez-Reyes A; Rivin Del Campo E; Praena-Fernandez JM; Azinovic I
    Clin Transl Oncol; 2015 Nov; 17(11):925-31. PubMed ID: 26108408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
    Qiu S; Lin S; Tham IW; Pan J; Lu J; Lu JJ
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):676-83. PubMed ID: 22024207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
    Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: a retrospective study.
    Qiu S; Lu J; Zheng W; Xu L; Lin S; Huang C; Xu Y; Huang L; Pan J
    BMC Cancer; 2014 Nov; 14():797. PubMed ID: 25366703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.
    Du L; Zhang XX; Feng LC; Qu BL; Chen J; Yang J; Liu HX; Xu SP; Xie CB; Ma L
    BMC Cancer; 2017 Aug; 17(1):582. PubMed ID: 28851315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experience.
    Jiang F; Jin T; Feng XL; Jin QF; Chen XZ
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C179-84. PubMed ID: 26506872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival outcomes and toxicity profiles among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT) versus IMRT + carbon-ion radiotherapy: A propensity score-matched analysis.
    Li Y; Guan X; Xing X; Hu C
    Head Neck; 2024 Jul; 46(7):1766-1776. PubMed ID: 38591178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
    Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
    Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.